Previous studies have found that IL-1β contributes to slow progressive chronic conditions such as atherosclerosis, diabetes, osteoarthritis and acute ischemic processes, including myocardial infarction and stroke (Gabay et al., 2010; Kerr et al., 2018a). Here, IL1B is linked to atherosclerosis.